Correction: Involvement of Exosomal Non-Coding RNAs in Osteoarthritis

Overview

This correction addresses the affiliation errors for author Jiayou Wen in the article on exosomal non-coding RNAs in osteoarthritis. The updated affiliation reflects the accurate institutional association.

Background

Osteoarthritis (OA) is a common degenerative joint disorder with complex molecular mechanisms. Understanding the roles of exosomal non-coding RNAs in OA could provide insights into potential therapeutic targets. However, current clinical guidelines do not incorporate exosomal approaches, emphasizing the need for further research in this area.

Data Highlights

No numerical or trial data is presented in the correction article.

Key Findings

• Correction of Jiayou Wen's affiliation to the School of Traditional Chinese and Western Medicine, Gansu University of Chinese Medicine.
• Removal of the incorrect affiliation for Jiayou Wen from the Department of Rehabilitation Medicine.
• The original article has been updated to reflect these changes.
• Exosomes are noted for their potential in influencing the joint microenvironment in OA.
• Current guidelines do not include recommendations for exosomal diagnostics or therapies in OA management.

Clinical Implications

Accurate author affiliations are essential for the integrity of scientific communication. The ongoing exploration of exosomal non-coding RNAs in OA highlights a developing area of research that may influence future therapeutic strategies.

Conclusion

Revise to eliminate unsupported claims about the necessity of continued research.

Related Resources & Content

1. Lu J, Wen J, Ji J, Front. Immunol., 2026 -- Correction: Involvement of Exosomal Non-Coding RNAs in Osteoarthritis
2. Frontiers in Immunology — Unlocking the potential of engineered exosomes for knee osteoarthritis therapy
3. Frontiers in Immunology — Integrative multi-omics identifies MSR1 as a programmed cell death and extracellular matrix hub gene in osteoarthritis with hesperidin targeting potential
4. conexiant — Three Genes May Help Distinguish RA From OA
5. Frontiers in Immunology — Denosumab in osteoarthritis: from mechanism to clinical translation
6. Recommendations Management | EULAR
7. Frontiers | Roles of exosomal non-coding RNAs in osteoarthritis